Nutraceuticals alone or with ezetimibe aid in dyslipidemia

December 10, 2015
Nutraceuticals alone or with ezetimibe aid in dyslipidemia

(HealthDay)—For statin-intolerant patients with dyslipidemia with ischemic heart disease treated with percutaneous coronary intervention, nutraceuticals alone or in combination with ezetimibe improve the lipid profile, according to a study published in the Dec. 15 issue of The American Journal of Cardiology.

Giuseppe Marazzi, M.D., Ph.D., from the Istituto di Ricerca a Carattere Scientifico San Raffaele Pisana in Rome, and colleagues conducted a randomized, prospective study comparing the safety and efficacy of a combination of nutraceuticals (red yeast rice, policosanol, berberine, folic acid, coenzyme Q10, and astaxanthin) and ezetimibe for three months. Patients who did not achieve their could add the alternative treatment for an additional 12 months. The authors enrolled 100 patients who were dyslipidemic with treated with (50 to nutraceuticals and 50 to ezetimibe).

The researchers found that 14 patients in the nutraceutical group and none in the ezetimibe group achieved their therapeutic target ( <100 mg/dL) after three months. The therapeutic goal was reached by 72.8 percent of the combined therapy group and by 100 percent of the nutraceutical group at one-year follow-up. There were no reports of important undesirable effects.

"Nutraceuticals alone or in combination with ezetimibe are well tolerated and improve the lipid profile in statin-intolerant patients with coronary heart disease," the authors write. "Further studies are needed to assess long-term effects of nutraceuticals on mortality."

Explore further: Statin treatment linked to reduced risk of cataracts

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Statin treatment linked to reduced risk of cataracts

December 7, 2015
(HealthDay)—Statin treatment is associated with reduced risk of incident cataract development, according to a study published in the Dec. 15 issue of The American Journal of Cardiology.

Atorvastatin/Ezetimibe beats atorvastatin after PCI

July 29, 2015
(HealthDay)—For Japanese patients who have undergone percutaneous coronary intervention (PCI), atorvastatin plus ezetimibe is associated with improved outcomes versus atorvastatin alone, according to a study published in ...

Preventable onset of myocardial infarction through coadministration of two drugs

July 30, 2015
Ischemic heart disease is the leading cause of death in the world and second in Japan behind cancer. It causes blood vessels to become clogged or narrowed through the buildup of cholesterol plaque along the inside of artery ...

Ezetimibe reduces cardiovascular events in diabetics with recent acute coronary syndrome

August 30, 2015
Ezetimibe reduces cardiovascular events in patients with diabetes and a recent acute coronary syndrome, according to a subgroup analysis of the IMPROVE-IT trial presented at ESC Congress today by co-principal investigator ...

Ezetimibe not tied to higher cancer risk, mortality

November 12, 2014
(HealthDay)—Treatment with the lipid-lowering therapy ezetimibe/simvastatin is not associated with an increased risk of developing cancer or an increased risk of dying from cancer, according to research published in the ...

Significantly improved chance of heart attack survival with high-potency statin treatment

February 20, 2014
(Medical Xpress)—A study looking at the data of thousands of patients who suffered heart attacks has suggested treatment with high-potency statins offers a significantly improved chance of survival compared to those taking ...

Recommended for you

Study shows in-home therapy effective for stroke rehabilitation

May 24, 2018
In-home rehabilitation, using a telehealth system and supervised by licensed occupational/physical therapists, is an effective means of improving arm motor status in stroke survivors, according to findings presented by University ...

New guidelines mean 1 in 3 adults may need blood pressure meds

May 23, 2018
(HealthDay)—One out of every three U.S. adults has high blood pressure that should be treated with medication, under guidelines recently adopted by the two leading heart health associations.

Surgery involving ultrasound energy found to treat high blood pressure

May 23, 2018
An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University ...

To have or not to have... your left atrial appendage closed

May 22, 2018
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where ...

Daily egg consumption may reduce cardiovascular disease

May 21, 2018
People who consume an egg a day could significantly reduce their risk of cardiovascular diseases compared with eating no eggs, suggests a study carried out in China, published in the journal Heart.

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.